Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yabao Pharmaceutical Group CoSHSE:600351 +0.46%67 Days Inventory is 104.09 as of Mar. 2026, which is 34% below its 10-year median of 158.75. GuruFocus rates SHSE:600351 with a GF Score™ of 67/100 and a GF Value™ of ¥5.53 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, Yabao Pharmaceutical Group Co ranks better than 73.07% on this metric.
The historical rank and industry rank for Yabao Pharmaceutical Group Co's Days Inventory or its related term are showing as below:
SHSE:600351'
s Days Inventory Range Over the Past 10 Years
Min: 114.49 Med: 158.75 Max: 184.21
Current: 114.49
During the past 13 years, Yabao Pharmaceutical Group Co's highest Days Inventory was 184.21. The lowest was 114.49. And the median was 158.75.
SHSE:600351's Days Inventory is ranked better than 73.07% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs SHSE:600351: 114.49
Inventory Turnover measures how fast the company turns over its inventory within a year.
Yabao Pharmaceutical Group Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.88.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Yabao Pharmaceutical Group Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.53.
Yabao Pharmaceutical Group Co (SHSE:600351) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Yabao Pharmaceutical Group Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Yabao Pharmaceutical Group Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Yabao Pharmaceutical Group Co Days Inventory Related Terms
Yabao Pharmaceutical Group Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yabao Pharmaceutical Group Co Days Inventory Chart
SHSE:600351 vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Yabao Pharmaceutical Group Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yabao Pharmaceutical Group Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Yabao Pharmaceutical Group Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Yabao Pharmaceutical Group Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yabao Pharmaceutical Group Co (SHSE:600351) has a Days Inventory of 104.09 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Yabao Pharmaceutical Group Co and its competitors. This is 34% below median its historical median of 158.75. Over the past decade, Yabao Pharmaceutical Group Co's Days Inventory has ranged from 114.49 to 184.21. According to the industry distribution chart, Yabao Pharmaceutical Group Co ranks #248 out of 921 companies in the Drug Manufacturers industry, placing it in the top 26.9%.
Is Yabao Pharmaceutical Group Co's Days Inventory too high?
Yabao Pharmaceutical Group Co's current Days Inventory of 104.09 is 34% below median its 10-year median of 158.75. Over the past 10 years, this metric has ranged from a low of 114.49 to a high of 184.21. The Drug Manufacturers industry median Days Inventory is 164.48. Yabao Pharmaceutical Group Co's value of 104.09 is 36.7% below this industry median. Based on the distribution chart, Yabao Pharmaceutical Group Co ranks #248 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Yabao Pharmaceutical Group Co has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yabao Pharmaceutical Group Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Yabao Pharmaceutical Group Co ranks #248 out of 921 companies for Days Inventory. This puts Yabao Pharmaceutical Group Co in the upper half of its industry. The industry median Days Inventory is 164.48. Yabao Pharmaceutical Group Co's value of 104.09 is 36.7% below this benchmark. Historically, Yabao Pharmaceutical Group Co's own Days Inventory has ranged from 114.49 to 184.21 over the past decade. While the company's 10-year median is 158.75 vs. the industry median of 164.48, Yabao Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yabao Pharmaceutical Group Co's current Days Inventory of 104.09 is 36.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Yabao Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yabao Pharmaceutical Group Co's current Days Inventory is 104.09, which is 34% below median its own 10-year median of 158.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yabao Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yabao Pharmaceutical Group Co (SHSE:600351) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥5.53, compared to a current price of ¥6.59 — trading 19.2% above its estimated fair value. The current Days Inventory is 104.09, which is 34% below median its 10-year median of 158.75 and 36.7% below the Drug Manufacturers industry median of 164.48. Yabao Pharmaceutical Group Co's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Yabao Pharmaceutical Group Co (SHSE:600351), the current Days Inventory is 104.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yabao Pharmaceutical Group Co (SHSE:600351) Overvalued in 2026?
Based on GuruFocus' analysis, Yabao Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of ¥6.59 is trading 19.2% above its estimated GF Value™ of ¥5.53.
GuruFocus considers Yabao Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for SHSE:600351:
Days Inventory: 104.09 (34% below median its 10-year median of 158.75)
GF Value™: ¥5.53 vs. price of ¥6.59 (19.2% above fair value)
Industry Position: 36.7% below the Drug Manufacturers median (#248 of 921)
No single metric tells the full story. See the SHSE:600351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yabao Pharmaceutical Group Co Business Description
Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.
67GF Score
Get the complete analysis for SHSE:600351
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600351 has been successfully added to your 
